1. Home
  2. NNNN vs GDV Comparison

NNNN vs GDV Comparison

Compare NNNN & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • GDV
  • Stock Information
  • Founded
  • NNNN 2021
  • GDV 2003
  • Country
  • NNNN Germany
  • GDV United States
  • Employees
  • NNNN N/A
  • GDV N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GDV Investment Managers
  • Sector
  • NNNN Health Care
  • GDV Finance
  • Exchange
  • NNNN Nasdaq
  • GDV Nasdaq
  • Market Cap
  • NNNN 2.2B
  • GDV 2.4B
  • IPO Year
  • NNNN 2025
  • GDV N/A
  • Fundamental
  • Price
  • NNNN $23.92
  • GDV $27.42
  • Analyst Decision
  • NNNN
  • GDV
  • Analyst Count
  • NNNN 0
  • GDV 0
  • Target Price
  • NNNN N/A
  • GDV N/A
  • AVG Volume (30 Days)
  • NNNN 76.5K
  • GDV 186.0K
  • Earning Date
  • NNNN 11-07-2025
  • GDV 01-01-0001
  • Dividend Yield
  • NNNN N/A
  • GDV 5.81%
  • EPS Growth
  • NNNN N/A
  • GDV N/A
  • EPS
  • NNNN 0.06
  • GDV N/A
  • Revenue
  • NNNN $8,185,146.00
  • GDV N/A
  • Revenue This Year
  • NNNN N/A
  • GDV N/A
  • Revenue Next Year
  • NNNN N/A
  • GDV N/A
  • P/E Ratio
  • NNNN $442.46
  • GDV N/A
  • Revenue Growth
  • NNNN 21.95
  • GDV N/A
  • 52 Week Low
  • NNNN $5.18
  • GDV $18.04
  • 52 Week High
  • NNNN $55.65
  • GDV $23.00
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 35.64
  • GDV 60.22
  • Support Level
  • NNNN $26.05
  • GDV $27.25
  • Resistance Level
  • NNNN $30.65
  • GDV $27.58
  • Average True Range (ATR)
  • NNNN 2.72
  • GDV 0.37
  • MACD
  • NNNN -0.11
  • GDV 0.05
  • Stochastic Oscillator
  • NNNN 19.80
  • GDV 85.71

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.

Share on Social Networks: